Narayana Hrudayalaya Ltd. · NSE:NH
Narayana Hrudayalaya — Q3 FY2019 Earnings Presentation
13 slides from Narayana Hrudayalaya's earnings presentation, Jan 31, 2019
Slide 1: N-1 Narayana Health submission letter to stock exchanges
h,v N-1 Narayana Health Date of Submission 31" January 2019 To To The Secretary The Secretary Listing Department Listing Depanment BSE l1m1ted National Stock Exchange or India limned Depanment of Corporate SeMces Exchange Plaza, Sandra Kurla Complex Phiroze JeeJeebhoy Towers, Mumbai - 400 OSO Dalal
Slide 2: Investor Presentation January 2019
Investor Presentation January 2019
Slide 3: Important Disclosure
Important Disclosure No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as of its da
Slide 4: NH at a Glance
NH at a Glance As on 31st Dec 2018 NH’s footprint in India 50 Healthcare Facilities Operational beds 21 Owned / Operated Hospitals(1) 5,243 Beds Kakriyal, Jammu Northern Region 2 Managed Hospitals(2) 498 Beds 3 hospitals Operational beds: 586 7 Heart Centres 371 Beds 19 Primary Healthcare Facilities
Slide 5: Key Highlights
Key Highlights ▪ We performed over 140 bone marrow transplants, almost 500 kidney transplants, 15 heart and 12 liver transplants across our Indian network during 9 months ended December 2018 ▪ Mazumdar Shaw Medical Center, Bengaluru, achieved the feat of completing 1,000 bone marrow transplants sinc
Slide 6: Revenue Mix – India Business (Q3 FY19)
Revenue Mix – India Business (Q3 FY19) Operating Revenues Business Mix INR mn 18,284 16,341 94% 5% 1% 5,538 6,284 (1) Owned / Operated Hospitals Heart Centres (2) Other Anciliary Businesses Q3 FY18 Q3 FY19 9M FY18 9M FY19 Speciality-Profile(7) Payee-Profile(3,8) Maturity-Wise(5) Cluster-Wise(5,6,8)
Slide 7: Operational Review – India Business
Operational Review – India Business Operational Beds(1) Discharges(2) 67,250 59,345 5,784 6,122 31st Dec 2017 31st Dec 2018 Q3 FY18 Q3 FY19 ARPOB(2) ALOS(2) INR mn Days 9.0 8.0 4.2 3.8 Q3 FY18 Q3 FY19 Q3 FY18 Q3 FY19 (1) Includes Managed Hospitals (2) Excludes Managed Hospitals 6
Slide 8: Operational Review – HCCI
Operational Review – HCCI ARPOB Discharges(1) US$ mn 576 504 1.9 1.6 Q3 FY18 Q3 FY19 Q3 FY18 Q3 FY19 Operating Revenues Profitability US$ mn US$ mn 14.5 EBITDA EBITDA Margin (%) 11.4 21.1% 15.3% 3.1 1.7 0.0 Q3 FY18 Q3 FY19 Q3 FY18 Q3 FY19 (1) ALOS for the period Q3 FY 19 was 5.8 and 5.6 in Q3 FY 18
Slide 9: Regional Profile – India Business (Q3 FY19)
Regional Profile – India Business (Q3 FY19) Region Hospitals(1) Hospital % of Hospital Operational Parameters(1) Operating Revenues(1) Operational Beds(1,3) % of Total(3) YoY Growth ARPOB (INR mn) Occupancy Karnataka 40% 6 45% 9.8 58% Region 10% Eastern 8 32% 32% 8.1 65% Region 6% Western 16% 4 14%
Slide 10: Maturity Profile – India Business (Q3 FY19)
Maturity Profile – India Business (Q3 FY19) Maturity(1) Hospitals (Exc. Hospital % of Hospital Key Performance Indicators(2) Managed Hospitals)(2) Operating Revenues(2) Operational Beds(2,5) % of Total YoY Growth ARPOB (INR mn) Occupancy EBITDAR Margin(3) Over 5 years 11 72% 69% 9.0 61% 23.2% 11% As
Slide 11: Profitability Snapshot – India Business
Profitability Snapshot – India Business EBITDA and EBITDA Margin Cost Structure INR mn Movement across New Hospitals % of Operating Revenues Q3 FY18 Q3 FY19 Losses Revenues 90.7% Rental / Revenue Share Losses Revenues 90.8% SRCC 69 56 SRCC 71 113 Dharamshila 12 191 Dharamshila 17 264 Gurugram 16 0 G
Slide 12: Consolidated Financial Performance
Consolidated Financial Performance Figures in INR mn, unless stated otherwise Profit and Loss Statement(1) Key Balance Sheet Items(1) Particulars (INR mn) Q3 FY19 9M FY19 Particulars 31st December 2018 Total Operating Revenue 7,321 20,957 Purchase of Medical Consumables, Drugs Shareholder Equity 10,
Slide 13: Shareholding Pattern
Shareholding Pattern Shareholding as on 31st December 2018(1) Total Number of Shares 204,360,804 ESOP Trust Others 0.9% 3.3% PE Investors 13.1%(3) CDC - 7.9% Asia Growth Capital - 5.2% FIIs / DIIs and Retail 18.9% Promoter Group FIIs - 10.4% 63.9%(2) DIIs - 4.0% Retail - 4.4% (1) Percentages might n
Narayana Hrudayalaya — Q3 FY2019 Earnings Presentation on 6ix